April 8, 2020
Vanderbilt University Medical Center and AstraZeneca join forces to identify potential COVID-19 treatments
Vanderbilt University Medical Center and the global biopharmaceutical company AstraZeneca have joined forces to identify candidates for antibody-based treatments that could protect people exposed to the 2019 novel coronavirus disease, COVID-19.
By Bill Snyder